Skip to main content
Premium Trial:

Request an Annual Quote

Bertrand Damour, Graham Cameron, Duncan Campbell, Michael Liebman, Darryl Pappin, John Kozarich, Jens Finnern, Ralph Humberg, Manfred Voglmaier, Jrgen Klenk

Premium

Bertrand Damour has been pro- moted from CFO to CEO of Geneva, Switzerland-based GeneProt. He replaces former CEO Cédric Loiret-Bernal, who left left the company last April.

Confirmant of Abingdon, UK, has elected new members to its scientific advisory board: Graham Cameron, associate director of the European Bioinformatics Institute in Cambridge; Duncan Campbell, director of the MRC HGMP Resource Center in Cambridge; and Michael Liebman, director for computational biology and biomedical informatics at the Abramson Cancer Center of the University of Pennsylvania.

Darryl Pappin has become director of chemistry, discovery proteomics, and the small molecule research center at Applied Biosystems in Framingham, Mass. He joined the company last fall from Imperial College London, where he was professor of proteomics. Previously, he was a senior scientist at Imperial Cancer Research Fund in London.

John Kozarich, CEO and CSO of ActivX Biosciences, based in La Jolla, Calif., has been elected to the board of directors of San Diego-based Ligand Pharmaceuticals.

Definiens of Munich has added to its management team: Jens Finnern, director for business development, joins the company from the German Cancer Research Institute, where he was executive managing director. Ralph Humberg, director for channel sales, was previously ADVA Optical Networking’s director for Asia-Pacific business. Manfred Voglmaier, director for sales, joins Definiens from NuGenesis Technologies, where he was managing director. In addition, J rgen Klenk has been promoted from director of R&D to vice president and chief technology officer.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.